On the fly News and insights, exclusive to thefly.com

EOLS

Evolus

$4.94 /

-0.22 (-4.27%)

12:41
06/02/20
06/02
12:41
06/02/20
12:41

Evolus falls after ITC extends determination target date by one month

Evolus disclosed earlier today that the administrate law judge assigned to the International Trade Commission action issued a decision extending the target date for an initial determination from June 5 to July 6. The decision also extended the target date for the final determination by the ITC from October 6 to November 6. The administrative law judge's decision regarding the extension of the target dates will become the decision of the ITC unless a party to the ITC action files a petition for review of the administrative law judge's decision, the company added. Evolus is a party to an ITC case which is entitled "In the Matter of Certain Botulinum Toxin Products." Shares of Evolus are down 4% to $4.92 in midday trading.

EOLS Evolus
$4.94 /

-0.22 (-4.27%)

05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
05/22/20 Barclays
News from Korea on Medytox has 'no implications' for Evolus, says Barclays
05/22/20 Cantor Fitzgerald
Evolus stock move likely good news, says Cantor Fitzgerald
05/13/20 Barclays
Evolus price target lowered to $4 from $9 at Barclays

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.